UChicago Medicine completes construction phase of AbbVie Foundation Cancer Pavilion

CHICAGO — University of Chicago Medicine reached a major infrastructure milestone on Sept. 24, 2026, officially completing the construction phase of the AbbVie Foundation Cancer Pavilion, according to a PR Newswire release dated Sept. 25, 2026. The 575,000-square-foot facility stands as the first and only freestanding cancer center of its kind in the state, shifting focus from physical buildout to operational readiness ahead of its scheduled clinical opening in April 2027.

Strategic Context

The completion of the physical structure concludes the heavy capital execution phase for the health system. Spanning 575,000 square feet, the AbbVie Foundation Cancer Pavilion is designed to consolidate specialized oncology services under a single roof, marking a significant addition to advanced cancer care infrastructure in the region. By establishing a dedicated, standalone facility supported by the AbbVie Foundation, UChicago Medicine secures a distinct operational footprint compared to institutions that rely on dispersed hospital wings for cancer treatment.

Forward Outlook

With construction behind them, project operators and clinical leadership are turning their focus toward facility preparation and clinical commissioning. The institution faces a strict operational timeline to complete interior finalization, system testing, and workflow validations before welcoming its first patients in April 2027. Healthcare operators and market observers will monitor how efficiently the health system transitions the massive square footage from a completed physical asset into an active clinical operation.